SCOPUS 정보 검색 플랫폼

Annals of Hematology

Volumn 93, Issue 6, 2014, Pages 1075-1076

Hepatitis B virus reactivation associated with ruxolitinib

(4) Shen, Chien Heng a,b Hwang, Cih En a Chen, Yi Yang a Chen, Chih Cheng a,b

a CHANG GUNG MEMORIAL HOSPITAL (Taiwan)

b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ENTECAVIR; RUXOLITINIB; VIRUS DNA;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; DRUG WITHDRAWAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; MALE; MYELOFIBROSIS; PRIORITY JOURNAL; TREATMENT RESPONSE; VIRUS REACTIVATION;

AGED; ANTIVIRAL AGENTS; ENZYME INHIBITORS; GUANINE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOCOMPROMISED HOST; JANUS KINASES; MALE; PRIMARY MYELOFIBROSIS; PYRAZOLES; THROMBOCYTHEMIA, ESSENTIAL; VIRUS ACTIVATION;

EID: 84902305390 PISSN: 09395555 EISSN: 14320584 Source Type: Journal
DOI: 10.1007/s00277-013-1936-5 Document Type: Letter

Times cited : (37)

References (7)

1
- 84857837774
- JAK inhibition with ruxolitinib versus best available therapy formyelofibrosis
- Harrison C, Kiladjian JJ, Al-Ali HK et al (2012) JAK inhibition with ruxolitinib versus best available therapy formyelofibrosis. N Engl J Med 366:787-798
- (2012) N Engl J Med , vol.366 , pp. 787-798
- Harrison, C.¹ Kiladjian, J.J.² Al-Ali, H.K.³

2
- 84863393110
- A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
- Verstovsek S, Mesa RA, Gotlib J et al (2012) A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N Engl J Med 366:799-807
- (2012) N Engl J Med , vol.366 , pp. 799-807
- Verstovsek, S.¹ Mesa, R.A.² Gotlib, J.³

3
- 84872065897
- JAKs and STATs in immunity, immunodeficiency, and cancer
- O 'Shea JJ, Holland SM, Staudt LM (2013) JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl JMed 368:161-170
- (2013) N Engl JMed , vol.368 , pp. 161-170
- O'Shea, J.J.¹ Holland, S.M.² Staudt, L.M.³

4
- 84864994569
- Jakinibs: A new class of kinase inhibitors in cancer and autoimmune disease
- Kontzias A, Kotlyar A, Laurence A et al (2012) Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease. Curr Opin Pharmacol 12:464-470
- (2012) Curr Opin Pharmacol , vol.12 , pp. 464-470
- Kontzias, A.¹ Kotlyar, A.² Laurence, A.³

5
- 84858855487
- JAK inhibitors for myeloproliferative neoplasms: Clarifying facts from myths
- Tefferi A (2012) JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths. Blood 119:2721-2730
- (2012) Blood , vol.119 , pp. 2721-2730
- Tefferi, A.¹

6
- 84880323178
- Progressive multifocal leukoencephalopathy associated with ruxolitinib
- Wathes R, Moule S, Milojkovic D (2013) Progressive multifocal leukoencephalopathy associated with ruxolitinib. N Engl J Med 369:197-198
- (2013) N Engl J Med , vol.369 , pp. 197-198
- Wathes, R.¹ Moule, S.² Milojkovic, D.³

7
- 84881416684
- Bilateral toxoplasmosis retinitis associated with ruxolitinib
- Goldberg RA, Reichel E, Oshry LJ (2013) Bilateral toxoplasmosis retinitis associated with ruxolitinib. N Engl J Med 369:681-683
- (2013) N Engl J Med , vol.369 , pp. 681-683
- Goldberg, R.A.¹ Reichel, E.² Oshry, L.J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.